Table 1.

Correlation between the clinicopathologic characteristics and the expression of ASPM in EC

variable	ASPM
	High	Low	P
age
≤50	17	20	0.863
>50	38	65
Stage
I	18	70	<0.0001*
II/III	37	15
Grade
I	16	29	0.534
II/III	39	56
Pathological type
Adenocarcinoma	45	70	0.936
Others	10	15
Menopausal status
Premenopausal	25	35	0.617
Postmenopausal	30	50

^*indicates a statistical significance.